After strengthening its balance sheet at the end of last year DryShips, Inc. (NASDAQ: DRYS), a diversified shipping company, planned to rebuild its depleted fleet and they have done exactly that. Since the beginning of this year the company has acquired 14 vessels, paying a total of $ 663 million and bringing the strength of its fleet back to 20 vessels. U.S. Stem Cell, Inc. (OTCQB: USRM) has received reactivation status of the MARVEL phase II/III trial with the Food and Drug Administration (FDA). The trial had previously been placed on "Inactive Status" as patients were not actively being enrolled. USRM is in the process of launching new clinics and programs in the Middle East and China that will feature its technologies, therapies, and products. American Leisure Holdings, Inc. (OTCBB: AMLH) recently announced that the company will be working with The Engine for upcoming series developments, including a winning line-up of eSports content for sale and distribution to both traditional network television and digital platforms. In March the company finalized a merger with GG Media Network, a rising eSports media production company. Ems Find, Inc. (OTCBB: EMSF) will be changing the name of the Company to Paradigm Group, Inc. The company intends to file with FINRA for approval of the name change for trading purposes and a new trading symbol. Ems Find, Inc., a wholly owned subsidiary of the Paradigm Group, Inc. is an applications and software development company focused on the healthcare transportation sector.

Our comprehensive report and the ticker we are initiating coverage on today can be viewed here with no obligation- http://tradersnewssource.com/traders-news-report/
 



DISCLOSURE

Traders News Source LLC (TNS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering small and micro-cap equity markets. TNS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE, NASDAQ and OTC exchanges. The other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
 
TNS has not been compensated; directly or indirectly; for producing or publishing this document.
 
PRESS RELEASE PROCEDURES

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a chartered financial analyst, for further information on analyst credentials, please email editor@tradersnewssource.com. TNS LLC editor Mark Roberts, (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written, and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author per the procedures outlined by TNS. TNS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents, or reports. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

TNS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake, or shortcoming. No liability is accepted whatsoever for any direct, indirect, or consequential loss arising from the use of this document. TNS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, TNS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.tradersnewssource.com.

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer be featured on our coverage list, contact us via email at: editor@tradersnewssource.com
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

CONTACT: editor@tradersnewssource.com
SOURCE: Traders News Source
 
 

US Stem Cell (CE) (USOTC:USRM)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more US Stem Cell (CE) Charts.
US Stem Cell (CE) (USOTC:USRM)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more US Stem Cell (CE) Charts.